Cause of death, by non-communicable diseases, ages 0-4, female in Japan
Japan: Cause of death, by non-communicable diseases, ages 0-4, female was 60.5% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, female in Japan, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 0-4.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 0-4, female in Japan is 60.5%, measured in 2021.
The figure is up 1.0% on the previous year and up 3.7% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, female in Japan peaked at 61.1% in 2015 and was at its lowest, 55.5%, in 2000.
That places Japan 1st out of 185 countries with data for 2021, putting it in the top 10%.
Cause of death, by non-communicable diseases, ages 0-4, female in Japan, year by year
| Year | % of total female deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 55.5% | — |
| 2010 | 58.3% | +5.1% |
| 2015 | 61.1% | +4.7% |
| 2019 | 60.1% | -1.6% |
| 2020 | 59.9% | -0.4% |
| 2021 | 60.5% | +1.0% |
Japan compared with similar countries
- Japan's 60.5% is above the median for high income countries, which is 42.8%, 1.4× the median. (58 countries reporting)
- Japan's 60.5% is above the median for East Asia & Pacific, which is 30.9%, 2.0× the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 55.5% | 55.5% | 55.5% | 1 |
| 2010s | 59.9% | 58.3% | 61.1% | 3 |
| 2020s | 60.2% | 59.9% | 60.5% | 2 |
Countries ranked near Japan
More health data for Japan
- Un projection of annual infant deaths, annual growth rate -2.73 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2774 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,294 deaths per 1,000 people (2090)
- Number of infants who die before age 1 178 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0155 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.36 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, female in Japan?
- Cause of death, by non-communicable diseases, ages 0-4, female in Japan was 60.5% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, female recorded in Japan?
- The highest recorded value was 61.1% in 2015.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, female recorded in Japan?
- The lowest recorded value was 55.5% in 2000.
- How does Japan rank for cause of death, by non-communicable diseases, ages 0-4, female?
- Japan ranks 1st out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, female rising or falling in Japan?
- Over the last ten years it is up 3.7%. The long-run trend across the full record is rising.
- Where does this Japan data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.